United States: Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book - Cooley LLP

Mondaq

23 Nov 2023 0 shares 1 views

United States: Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book - Cooley LLP

Mondaq

Published 23 Nov 2023

The US Federal Trade Commission (FTC) sent letters on November 7, 2023, accusing 10 companies of improperly listing drug delivery device patents in the US Food and Drug Administration (FDA)...

Full Article

United States: FTC Alleges Misuse Of Orange Book Listings: Puts10 Pharma Companies On Notice - Oblon, McClelland, Maier & Neustadt, L.L.P

On Tuesday, the FTC announced that it is cracking down on companies it asserts is improperly or inaccurately placing drugs on the..

Mondaq 15 Nov 2023

United States: Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book - Cooley LLP

United States: Following Recent Policy Statement, FTC 'Disputes' 100+ Patent Listings In FDA Orange Book - Cooley LLP

You might like

Related news coverage

United States: FTC Alleges Misuse Of Orange Book Listings: Puts10 Pharma Companies On Notice - Oblon, McClelland, Maier & Neustadt, L.L.P

Advertisement